Insider Transactions in Q4 2021 at Boston Scientific Corp (BSX)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 28
2021
|
Ian T Meredith EVP Global Chief Med Officer |
SELL
Open market or private sale
|
Direct |
7,018
-21.1%
|
$301,774
$43.21 P/Share
|
|
Dec 20
2021
|
David A Pierce EVP Pres MedSurg |
SELL
Open market or private sale
|
Direct |
49,988
-100.0%
|
$1,949,532
$39.9 P/Share
|
|
Dec 20
2021
|
David A Pierce EVP Pres MedSurg |
BUY
Exercise of conversion of derivative security
|
Direct |
47,931
+28.96%
|
$287,586
$6.84 P/Share
|
|
Dec 15
2021
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
3,321
-2.1%
|
$132,840
$40.83 P/Share
|
|
Dec 03
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
296
-0.22%
|
$11,544
$39.46 P/Share
|
|
Dec 03
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
649
+0.48%
|
-
|
|
Nov 15
2021
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
3,321
-2.06%
|
$139,482
$42.18 P/Share
|
|
Nov 15
2021
|
David S Wichmann Director |
BUY
Open market or private purchase
|
Direct |
25,000
+50.0%
|
$1,025,000
$41.98 P/Share
|
|
Nov 12
2021
|
Michael F Mahoney Chairman, President & CEO |
SELL
Bona fide gift
|
Direct |
34,900
-1.68%
|
-
|
|
Nov 01
2021
|
Michael F Mahoney Chairman, President & CEO |
SELL
Open market or private sale
|
Direct |
201,042
-8.81%
|
$8,644,806
$43.05 P/Share
|
|
Nov 01
2021
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
201,042
+4.28%
|
$1,206,252
$6.84 P/Share
|
|
Oct 22
2021
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
SELL
Open market or private sale
|
Direct |
727
-3.56%
|
$32,715
$45.0 P/Share
|
|
Oct 15
2021
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
3,322
-2.02%
|
$142,846
$43.58 P/Share
|
|
Oct 04
2021
|
Michael F Mahoney Chairman, President & CEO |
SELL
Open market or private sale
|
Direct |
201,042
-4.5%
|
$8,443,764
$42.91 P/Share
|
|
Oct 04
2021
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
201,042
+4.28%
|
$1,206,252
$6.84 P/Share
|
|
Oct 02
2021
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,137
-3.69%
|
$48,891
$43.8 P/Share
|
|
Oct 02
2021
|
Vance R Brown SVP, GC and Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
3,393
+9.91%
|
-
|
|
Oct 01
2021
|
Scott Olson SVP & Pres, CRM, Diagnostics |
SELL
Open market or private sale
|
Direct |
700
-5.2%
|
$30,100
$43.49 P/Share
|